UK markets closed

Nanophase Technologies Corporation (NANX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.3700+0.2200 (+19.13%)
At close: 03:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1500
Open1.2800
Bid0.0000 x 0
Ask0.0000 x 0
Day's range1.1500 - 1.3700
52-week range0.3200 - 1.4900
Volume54,683
Avg. volume11,977
Market cap75.147M
Beta (5Y monthly)1.49
PE ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings date24 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1.50
  • Insider Monkey

    Nanophase Technologies Corporation (PNK:NANX) Q1 2024 Earnings Call Transcript

    Nanophase Technologies Corporation (PNK:NANX) Q1 2024 Earnings Call Transcript April 24, 2024 Nanophase Technologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to today’s program entitled Nanophase’s First Quarter 2024 Financial Conference […]

  • GlobeNewswire

    Nanophase Reports Record First Quarter Results

    — Delivered $9.9 Million in Q1 Revenue— $0.9 Million in Profit— BASF Litigation Resolved ROMEOVILLE, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the first quarter ended March 31, 2024. Jess Jankowski

  • GlobeNewswire

    Nanophase Technologies Announces First Quarter 2024 Financial Release and Conference Call Details

    Romeoville, Ill., April 19, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2024 after market close on Tuesday, April 23, 2024, with an investor conference call to f